Jci_page_head_homepage_01 Jci_page_head_homepage_02
Cindy S. Ma, Stefania Pittaluga, Danielle T. Avery, Nathan J. Hare, Irina Maric, Amy D. Klion, Kim E. Nichols, Stuart G. Tangye
Published in Volume 116, Issue 2
J Clin Invest. 2006; 116(2):322–333 doi:10.1172/JCI25720
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

Deficiency of GCs in spleens of XLP patients. Immunohistology was performed on spleen sections obtained from normal donors (AC), EBV XLP patients (D, XLP#11; E and F, XLP#10), and EBV+ XLP patients obtained from the XLP Registry (G and H, XLP-K001; see ref. 28). Gastrointestinal tissue obtained from another XLP patient (I, XLP-K004; see ref. 28) was also examined. Anti-IgD (A, B, D, E, H, and I), anti-CD27 (A, D, and G), and anti–Bcl-6 (C and F) were used to identify the B cell follicle (IgD+CD27Bcl-6), marginal zone (MZ; IgDloCD27+Bcl-6), GC (IgDBcl-6+), and T cell zone (T; IgDCD27+) in sections of human spleen and GIT. Rare Bcl-6+ secondary follicles were noted in XLP#10; in addition, the absence of IgD B cells within a B cell follicle (XLP#11, XLP-K001) revealed the paucity of appropriately formed GCs in the spleens of these XLP patients.